New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, ...
Isomab Ltd ("Isomab") a UK-based biotechnology company developing novel therapies to restore vascularization in ...
MedPage Today on MSN
New easier-to-use GLP-1 pill safe for the heart, study says
Orforglipron met expectations in ACHIEVE-4, with cardiovascular benefit yet to be proven ...
CryoTherapeutics announced treatment of the first patient in its ICECAP study, an important step in evaluating localized ...
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and ...
IntroductionRenal Artery Stenosis (RAS) is an important causative disease for secondary hypertension and ischemic nephropathy ...
Lucy Lazarony is an experienced personal finance journalist and writer who got her start in 1998 writing about financial topics. She writes accessible and easy-to-understand articles about credit, ...
Malaria case management, which consists of prompt diagnosis and effective treatment, remains a vital component of malaria control and elimination strategies. This third edition of the WHO Guidelines ...
2026 年 7 月 9 日发布的《国家基本药物目录（2026 年版）》将琥珀酸美托洛尔纳入目录，并于 2026 年 9 月 1 日起施行[1]。对于需要长期规范治疗的心血管疾病患者而言，纳入国家基本药物目录有助于推动相关药物在各级医疗卫生机构的规范配备与使用，患者可及性有望进一步提高。 琥珀酸美托洛尔属于相对选择性 β1受体阻滞剂，可通过减弱交感神经对心脏的刺激，减慢心率、降低心肌耗氧[2]。这 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results